Amphastar Pharmaceuticals, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €769.36M +13.3% €179.97M +9.3% 23.4% -0.0085 pp N/A N/A
    (estimated) €678.95M -2.2% €164.62M -3.6% 24.2% -0.0035 pp N/A N/A
    (estimated) €693.94M +4.6% €170.70M +9.0% 24.6% +0.010 pp N/A N/A
    (estimated) €663.42M +7.1% €156.58M +13.8% 23.6% +0.014 pp €136.47M +18.5% 20.6% +0.020 pp
    (estimated) €619.34M +1.9% €137.56M +1.1% 22.2% -0.0017 pp €115.15M -46.9% 18.6% -0.17 pp
    €608.00M +10.6% €136.06M +16.0% 22.4% +0.010 pp €217.01M +14.8% 35.7% +0.013 pp
    €549.64M +29.1% €117.32M +50.5% 21.3% +0.030 pp €189.07M +95.8% 34.4% +0.12 pp
    €425.61M +14.0% €77.95M +47.1% 18.3% +0.041 pp €96.57M -9.8% 22.7% -0.060 pp
    €373.39M +25.1% €52.98M +5,562.4% 14.2% +0.14 pp €107.00M +37.7% 28.7% +0.026 pp
    €298.40M +8.5% €935.69K -97.8% 0.3% -0.15 pp €77.72M +9.4% 26.0% +0.0020 pp
    €274.95M +9.4% €41.74M -952.9% 15.2% +0.17 pp €71.07M -2.0% 25.8% -0.030 pp
    €251.34M +22.7% -€4.89M -227.3% -1.9% -0.038 pp €72.50M +14.4% 28.8% -0.021 pp
    €204.86M -5.9% €3.85M -57.2% 1.9% -0.023 pp €63.38M +24.0% 30.9% +0.074 pp
    €217.64M +1.4% €8.98M -477.9% 4.1% +0.052 pp €51.13M +124.3% 23.5% +0.13 pp
    €214.53M +19.5% -€2.38M -74.0% -1.1% +0.040 pp €22.80M -35.7% 10.6% -0.091 pp
    €179.51M -8.4% -€9.13M -190.2% -5.1% -0.10 pp €35.44M -15.8% 19.7% -0.017 pp
    €195.91M +12.4% €10.12M -34.4% 5.2% -0.037 pp €42.09M +109.1% 21.5% +0.099 pp
    €174.28M €15.43M 8.9% €20.13M 11.5%

    Notifications